Under current Medicare rules, doctors generally can't refer patients to a pharmacy they own because of conflict-of-interest protections (known as the physician self-referral or "Stark Law" prohibition). This bill would create a temporary exception from 2026 through 2030, allowing doctors to dispense certain prescription drugs directly from their offices to patients they have an ongoing relationship with. It also requires the GAO to study whether these in-office dispensing arrangements lead to changes in prescribing patterns. The bill reduces the Medicare Improvement Fund by $18 million to offset costs.
Corporate Benefits
- Physician self-referral exception — Stark Law carve-out for in-office Part D drug dispensing, 2026–2030
- Medicare billing scope for physician group practices — Group practices may bill for drugs they prescribe and dispense in-office
Transparency & Accountability
- GAO study of dispensing-arrangement effects — Required within 3 years on prescribing-pattern changes and conflict-of-interest patterns
- Medicare Improvement Fund balance — Reduced by $18 million to offset costs
Congressional Summary
This bill temporarily expands flexibilities under the Stark law (i.e., the Physician Self-Referral Law) for certain physicians who dispense covered outpatient drugs under the Medicare prescription drug benefit at the physician's office location (e.g., through an integrated pharmacy). The Stark law generally prohibits physicians from referring patients to receive services that are payable under Medicare or Medicaid from entities in which the physician or an immediate family member has a financial relationship. Specifically, the bill allows, from 2026-2030, physicians to dispense such drugs from the physician's office, including through in-person pickup by a caregiver or via mail, if (1) the physician prescribed the drug, (2) the beneficiary has an ongoing relationship with the physician, (3) the beneficiary had at least one face-to-face visit with the physician in the prior year, and (4) the physician bills for the drug. These requirements also apply to physicians within the same group practice.The Government Accountability Office must report on pharmacies or pharmacy networks that dispense significantly more covered drugs under the Medicare prescription drug benefit after the bill's enactment, the extent to which such pharmacies and networks are owned by physicians or integrated into physician practices, and the common characteristics of these types of arrangements.
Legislative Subjects
Details
- Congress
- 119th
- Chamber
- House
- Status
- summarized
- Action
- Introduced in House
- Action Date
- 2025-03-31
- Date Added
- 2026-04-15
- Source
- Congress.gov →
Like reading a bill in plain English?
We're building an app that does this for every bill in Congress and lets you tell your reps how you want them to vote. We're a small team getting ready to launch, and we're trying to show investors that real people want this. Be one of them. Help us get it built. Leave your email and we'll tell you the moment the app is ready.